{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T09:13:56Z","timestamp":1767172436748,"version":"build-2238731810"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","award":["22SE1P0051"],"award-info":[{"award-number":["22SE1P0051"]}],"id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Res Notes"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s13104-016-2262-5","type":"journal-article","created":{"date-parts":[[2016,10,7]],"date-time":"2016-10-07T06:47:54Z","timestamp":1475822874000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["A feasibility study of the clinical effectiveness and cost-effectiveness of individual cognitive behavioral therapy for panic disorder in a Japanese clinical setting: an uncontrolled pilot study"],"prefix":"10.1186","volume":"9","author":[{"given":"Yoichi","family":"Seki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinobu","family":"Nagata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayuki","family":"Shibuya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Yoshinaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mizue","family":"Yokoo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanae","family":"Ibuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noriko","family":"Minamitani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muga","family":"Kusunoki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasushi","family":"Inada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuko","family":"Kawasoe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soichiro","family":"Adachi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kensuke","family":"Yoshimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michiko","family":"Nakazato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaomi","family":"Iyo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akiko","family":"Nakagawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eiji","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,10,7]]},"reference":[{"key":"2262_CR1","doi-asserted-by":"crossref","DOI":"10.1176\/appi.books.9780890425596","volume-title":"Diagnostic and statistical manual of mental disorders","author":"American Psychiatric Association","year":"2013","unstructured":"American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Washington, DC: American Psychiatric Association; 2013.","edition":"5"},{"key":"2262_CR2","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1001\/archpsyc.63.4.415","volume":"63","author":"RC Kessler","year":"2006","unstructured":"Kessler RC, Chiu WT, Jin R, Ruscio AM, Shear K, Walters EE. The epidemiology of panic attacks, panic disorder and agoraphobia in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2006;63:415\u201324.","journal-title":"Arch Gen Psychiatry"},{"key":"2262_CR3","volume-title":"Global burden of panic disorder in the year 2000","author":"JL Ayusuo-Mateos","year":"2000","unstructured":"Ayusuo-Mateos JL. Global burden of panic disorder in the year 2000. Geneva: World Health Organization; 2000."},{"key":"2262_CR4","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/j.1440-1819.2006.01492.x","volume":"60","author":"Y Naganuma","year":"2006","unstructured":"Naganuma Y, Tachimori H, Kawakami N, Takeshima T, Ono Y, Uda H, Hata Y, Nakane Y, Nakane H, Iwata N, Furukawa TA, Kikkawa T. Twelve-month use of mental health services in four areas in Japan: findings from the World Mental Health Japan Survey 2002\u20132003. Psychiatry Clin Neurosci. 2006;60:240\u20138.","journal-title":"Psychiatry Clin Neurosci"},{"key":"2262_CR5","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jpsychores.2014.04.005","volume":"77","author":"M Goorden","year":"2014","unstructured":"Goorden M, Muntingh A, van Marwijk H, Spinhoven P, Ad\u00e8r H, van Balkom A, van der Feltz-Cornelis C, Hakkaart-van Roijen L. Cost utility analysis of a collaborative stepped care intervention for panic and generalized anxiety disorders in primary care. J Psychosom Res. 2014;77:57\u201363.","journal-title":"J Psychosom Res"},{"key":"2262_CR6","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.eurpsy.2010.06.004","volume":"26","author":"P Skapinakis","year":"2011","unstructured":"Skapinakis P, Glyn Lewis G, Davies S, Singleton N. Panic disorder and subthreshold panic in the UK general population: epidemiology, comorbidity and functional limitation. Eur Psychiatry. 2011;26:354\u201362.","journal-title":"Eur Psychiatry"},{"key":"2262_CR7","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1017\/S1461145705005201","volume":"8","author":"A Bakker","year":"2005","unstructured":"Bakker A, van Balkom AJ, Stein DJ. Evidence-based pharmacotherapy of panic disorder. Int J Neuropsychopharmacol. 2005;8:473\u201382.","journal-title":"Int J Neuropsychopharmacol"},{"key":"2262_CR8","doi-asserted-by":"crossref","first-page":"779","DOI":"10.2147\/NDT.S1224","volume":"4","author":"C Pull","year":"2008","unstructured":"Pull C, Damsa C. Pharmacotherapy of panic disorder. Neuropsychiatr Dis Treat. 2008;4:779\u201395.","journal-title":"Neuropsychiatr Dis Treat"},{"key":"2262_CR9","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/acps.12169","volume":"129","author":"FJ Apeldoorn","year":"2013","unstructured":"Apeldoorn FJ, Stant AD, Hout WJ, Mersch PP, Boer JA. Cost-effectiveness of CBT, SSRI, and CBT+ SSRI in the treatment for panic disorder. Acta Psychiatr Scand. 2013;129:286\u201395.","journal-title":"Acta Psychiatr Scand"},{"key":"2262_CR10","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1001\/jama.283.19.2529","volume":"19","author":"DH Barlow","year":"2000","unstructured":"Barlow DH, Gorman JM, Shear MK, Woods SW. Cognitive-behavioral therapy, imipramine, or their combination for panic disorder: a randomized controlled trial. JAMA. 2000;19:2529\u201336.","journal-title":"JAMA"},{"key":"2262_CR11","doi-asserted-by":"crossref","first-page":"621","DOI":"10.4088\/JCP.v69n0415","volume":"69","author":"SG Hofmann","year":"2008","unstructured":"Hofmann SG, Smits JAJ. Cognitive-behavioral therapy for adult anxiety disorders: a meta-analysis of randomized placebo controlled trials. J Clin Psychiatry. 2008;69:621\u201332.","journal-title":"J Clin Psychiatry"},{"key":"2262_CR12","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1002\/da.20829","volume":"28","author":"B Roshanaei-Moghaddam","year":"2011","unstructured":"Roshanaei-Moghaddam B, Pauly MC, Atkins DC, Baldwin SA, Stein MB, Roy-Byrne P. Relative effects of CBT and pharmacotherapy in depression versus anxiety: is medication somewhat better for depression, and CBT somewhat better for anxiety? Depress Anxiety. 2011;28:560\u20137.","journal-title":"Depress Anxiety"},{"key":"2262_CR13","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/j.1600-0447.2006.00839.x","volume":"115","author":"E M\u00f6rtberg","year":"2007","unstructured":"M\u00f6rtberg E, Clark DM, Sundin O, Aberg Wistedt A. Intensive group cognitive treatment and individual cognitive therapy vs. treatment as usual in social phobia: a randomized controlled trial. Acta Psychiatr Scand. 2007;115:142\u201354.","journal-title":"Acta Psychiatr Scand"},{"key":"2262_CR14","doi-asserted-by":"crossref","first-page":"337","DOI":"10.31887\/DCNS.2015.17.3\/akaczkurkin","volume":"17","author":"AN Kaczkurkin","year":"2015","unstructured":"Kaczkurkin AN, Foa EB. Cognitive-behavioral therapy for anxiety disorders: an update on the empirical evidence. Dialogues Clin Neurosci. 2015;17:337\u201346.","journal-title":"Dialogues Clin Neurosci"},{"key":"2262_CR15","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1037\/0022-006X.65.2.203","volume":"65","author":"DM Clark","year":"1997","unstructured":"Clark DM, Salkovskis PM, \u00d6st LG, Breitholtz E, Koehler KA, Westling BE, Jeavons A, Gelder M. Misinterpretation of body sensations in panic disorder. J Consult Clin Psychol. 1997;65:203\u201313.","journal-title":"J Consult Clin Psychol"},{"key":"2262_CR16","first-page":"69","volume-title":"Social phobia: diagnosis, assessment, and treatment","author":"D Clark","year":"1995","unstructured":"Clark D, Wells A. A cognitive model of social phobia. In: Heimberg RG, Liebowitz MR, Hope DA, Schneier FR, editors. Social phobia: diagnosis, assessment, and treatment. New York: Guilford Press; 1995. p. 69\u201393."},{"key":"2262_CR17","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/acps.12169","volume":"129","author":"FJ Apeldoorn van","year":"2014","unstructured":"van Apeldoorn FJ, Stant D, Hout J, Mersch PP, den Boer JA. Cost-effectiveness of CBT, SSRI, and CBT+ SSRI in the treatment for panic disorder. Acta Psychiatr Scand. 2014;129:286\u201395.","journal-title":"Acta Psychiatr Scand"},{"key":"2262_CR18","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1093\/heapol\/czl018","volume":"21","author":"F Sassi","year":"2006","unstructured":"Sassi F. Calculating QALYs, comparing QALY and DALY calculations. Health Policy Plan. 2006;21:402\u20138.","journal-title":"Health Policy Plan"},{"key":"2262_CR19","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1159\/000228248","volume":"78","author":"DC Mohr","year":"2009","unstructured":"Mohr DC, Spring B, Freedland KE, Beckner V, Arean P, Hollon SD, Ockene J, Kaplan R. The selection and design of control conditions for randomized controlled trials of psychological interventions. Psychother Psychosom. 2009;78:275\u201384.","journal-title":"Psychother Psychosom"},{"key":"2262_CR20","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0022-3956(01)00028-0","volume":"35","author":"MK Shear","year":"2001","unstructured":"Shear MK, Rucci P, Williams J, Frank E, Grochocinski V, Vander Bilt J, Houck P, Wang T. Reliability and validity of the Panic Disorder Severity Scale: replication and extension. J Psychiatr Res. 2001;35:293\u20136.","journal-title":"J Psychiatr Res"},{"key":"2262_CR21","first-page":"22","volume":"59","author":"DV Sheehan","year":"1998","unstructured":"Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, Hergueta T, Baker R, Dunbar GC. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59:22\u201333.","journal-title":"J Clin Psychiatry"},{"key":"2262_CR22","first-page":"43","volume":"39","author":"DV Sheehan","year":"2010","unstructured":"Sheehan DV, Lecrubier Y, Otsubo T. Brief structured interview for psychiatric disorders: M.I.N.I. and M.I.N.I. KID. Rinsho-Seishin-Igaku. 2010;39:43\u20138.","journal-title":"Rinsho-Seishin-Igaku"},{"key":"2262_CR23","doi-asserted-by":"crossref","first-page":"e002242","DOI":"10.1136\/bmjopen-2012-002242","volume":"3","author":"N Yoshinaga","year":"2013","unstructured":"Yoshinaga N, Niitsu T, Hanaoka H, Sato Y, Ohshima F, Matsuki S, Kobori O, Nakazato M, Nakagawa A, Iyo M, Shimizu E. Strategy for treating selective serotonin reuptake inhibitor-resistant social anxiety disorder in the clinical setting: a randomised controlled trial protocol of cognitive behavioural therapy in combination with conventional treatment. BMJ Open. 2013;3:e002242.","journal-title":"BMJ Open"},{"key":"2262_CR24","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/1756-0500-6-74","volume":"6","author":"N Yoshinaga","year":"2013","unstructured":"Yoshinaga N, Ohshima F, Matsuki S, Tanaka M, Kobayashi T, Ibuki H, Asano K, Kobori O, Shiraishi T, Ito E, Nakazato M, Nakagawa A, Iyo M, Shimizu E. A preliminary study of individual cognitive behavior therapy for social anxiety disorder in Japanese clinical settings: a single-arm, uncontrolled trial. BMC Res Notes. 2013;6:74.","journal-title":"BMC Res Notes"},{"key":"2262_CR25","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1159\/000444221","volume":"85","author":"N Yoshinaga","year":"2016","unstructured":"Yoshinaga N, Matsuki S, Niitsu T, Sato Y, Tanaka M, Ibuki H, Takanashi R, Ohshiro K, Ohshima F, Asano K, Kobori O, Yoshimura K, Hirano Y, Sawaguchi K, Koshizaka M, Hanaoka H, Nakagawa A, Nakazato M, Iyo M, Shimizu E. Cognitive behavioral therapy for patients with social anxiety disorder who remain symptomatic following antidepressant treatment: a randomized, assessor-blinded, controlled trial. Psychother Psychosom. 2016;85:208\u201317.","journal-title":"Psychother Psychosom"},{"key":"2262_CR26","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/978-3-642-73543-1_13","volume-title":"Panic and phobias","author":"DM Clark","year":"1988","unstructured":"Clark DM, Salkovskis PM, Gelder M, Koehler C, Martin M, Anastasiades P, Hackmann A, Middleton H, Jeavons A. Tests of a cognitive theory of panic. In: Hand I, Wittchen HU, editors. Panic and phobias, vol. 2. Berlin: Springer; 1988. p. 149\u201358."},{"key":"2262_CR27","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1017\/S1352465801004040","volume":"29","author":"IM Blackburn","year":"2001","unstructured":"Blackburn IM, James IA, Milne DL, Baker C, Standart S, Garland A, Reichelt FK. The revised Cognitive Therapy Scale (CTS-R): psychometric properties. Behav Cogn Psychother. 2001;29:431\u201346.","journal-title":"Behav Cogn Psychother"},{"key":"2262_CR28","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/da.10049","volume":"15","author":"PR Houck","year":"2002","unstructured":"Houck PR, Spiegel DA, Shear MK, Rucci P. Reliability of the self-report version of the Panic Disorder Severity Scale. Depress Anxiety. 2002;15:183\u20135.","journal-title":"Depress Anxiety"},{"key":"2262_CR29","first-page":"331","volume":"47","author":"M Katagami","year":"2007","unstructured":"Katagami M. The self-report version of the Panic Disorder Severity Scale: reliability and validity of the Japanese version. Jpn J Psychosom Med. 2007;47:331\u20138.","journal-title":"Jpn J Psychosom Med"},{"key":"2262_CR30","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/00004850-199506000-00003","volume":"10","author":"B Bandelow","year":"1995","unstructured":"Bandelow B. Assessing the efficacy of treatments for panic disorder and agoraphobia. II. The Panic and Agoraphobia Scale. Int Clin Psychopharmacol. 1995;10:73\u201381.","journal-title":"Int Clin Psychopharmacol"},{"key":"2262_CR31","first-page":"1053","volume":"37","author":"H Kaiya","year":"2008","unstructured":"Kaiya H, Yoshida E, Kumano H. Reliability and validity of the Japanese version of the Panic and Agoraphobia Scale (PAS-J). Rinsho-Seishin-Igaku. 2008;37:1053\u201364.","journal-title":"Rinsho-Seishin-Igaku"},{"key":"2262_CR32","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1001\/jama.282.18.1737","volume":"282","author":"RL Spitzer","year":"1999","unstructured":"Spitzer RL, Kroenke K, Williams JB. Validation and utility of a self-report version of PRIME-MD: PHQ primary care study. JAMA. 1999;282:1737\u201344.","journal-title":"JAMA"},{"key":"2262_CR33","first-page":"952","volume":"101","author":"K Muramatsu","year":"2007","unstructured":"Muramatsu K, Miyaoka H, Kamijima K, Muramatsu Y, Yoshida M, Otsubo T, Gejyo F. The patient health questionnaire, Japanese version: validity according to the Mini-International Neuropsychiatric Interview-Plus. Psychol Rep. 2007;101:952\u201360.","journal-title":"Psychol Rep"},{"key":"2262_CR34","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1001\/archinte.166.10.1092","volume":"166","author":"RL Spitzer","year":"2006","unstructured":"Spitzer RL, Kroenke K, Williams JB, L\u00f6we B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166:1092\u20137.","journal-title":"Arch Intern Med"},{"key":"2262_CR35","first-page":"35","volume":"7","author":"K Muramatsu","year":"2014","unstructured":"Muramatsu K. An up-to-date letter in the Japanese version of PHQ, PHQ-9, PHQ-15. Niigata Seiryo Daigakudaigakuin Rinshosinrigakukenkyu (Grad School Niigata Seiryo Uni Clin Psychol Res). 2014;7:35\u20139.","journal-title":"Niigata Seiryo Daigakudaigakuin Rinshosinrigakukenkyu (Grad School Niigata Seiryo Uni Clin Psychol Res)"},{"key":"2262_CR36","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1177\/0146167283093007","volume":"9","author":"MR Leary","year":"1983","unstructured":"Leary MR. A brief version of the Fear of Negative Evaluation Scale. Personal Soc Psychol Bull. 1983;9:371\u20135.","journal-title":"Personal Soc Psychol Bull"},{"key":"2262_CR37","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1037\/h0027806","volume":"33","author":"D Watson","year":"1969","unstructured":"Watson D, Friend R. Measurement of social-evaluative anxiety. J Consult Clin Psychol. 1969;33:448\u201357.","journal-title":"J Consult Clin Psychol"},{"key":"2262_CR38","first-page":"87","volume":"30","author":"S Sasagawa","year":"2004","unstructured":"Sasagawa S, Kanai Y, Muranaka Y, Suzuki S, Shimada H, Sakano Y. Development of a Short Fear of Negative Evaluation Scale for Japanese using item response theory. Koudou Ryouhou Kenkyu. 2004;30:87\u201398.","journal-title":"Koudou Ryouhou Kenkyu"},{"key":"2262_CR39","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0168-8510(90)90421-9","volume":"16","author":"EuroQol Group","year":"1990","unstructured":"EuroQol Group. A new facility for the measurement of health-related quality of life. Health Policy. 1990;16:199\u2013208.","journal-title":"Health Policy"},{"key":"2262_CR40","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/hec.673","volume":"11","author":"A Tsuchiya","year":"2002","unstructured":"Tsuchiya A, Ikeda S, Ikegami N, Nishimura S, Sakai I, Fukuda T, Hamashima C, Hisashige A, Tamura M. Estimating an EQ-5D population value set: the case of Japan. Health Econ. 2002;11:341\u201353.","journal-title":"Health Econ"},{"key":"2262_CR41","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1002\/hec.944","volume":"14","author":"A Manca","year":"2005","unstructured":"Manca A, Hawkins N, Sculpher MJ. Estimating mean QALYs in a trial-based cost-effectiveness analysis: the importance of controlling for baseline utility. Health Econ. 2005;14:487\u201396.","journal-title":"Health Econ"},{"key":"2262_CR42","volume-title":"Statistical power analysis in the behavioral sciences","author":"J Cohen","year":"1988","unstructured":"Cohen J. Statistical power analysis in the behavioral sciences. 2nd ed. Hillsdale: Erlbaum; 1988.","edition":"2"},{"key":"2262_CR43","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.14m09507","author":"B Milrod","year":"2015","unstructured":"Milrod B, Chambless DL, Gallop R, Busch FN, Schwalberg M, McCarthy KS, Gross C, Sharpless BA, Leon AC, Barber JP. Psychotherapies for panic disorder: a tale of two sites. J Clin Psychiatry. 2015. doi: 10.4088\/JCP.14m09507 (Epub ahead of print).","journal-title":"J Clin Psychiatry"},{"key":"2262_CR44","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1002\/hec.1481","volume":"19","author":"T Shiroiwa","year":"2010","unstructured":"Shiroiwa T, Sung YK, Fukuda T, Lang HC, Bae SC, Tsutani K. International survey on willingness-to-pay (WTP) for one additional QALY gained: what is the threshold of cost effectiveness? Health Econ. 2010;19:422\u201337.","journal-title":"Health Econ"},{"key":"2262_CR45","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.brat.2005.05.003","volume":"44","author":"E Heldt","year":"2006","unstructured":"Heldt E, Manfro G, Kipper L, Blaya C, Isolan L, Otto MW. One-year follow-up of pharmacotherapy-resistant patients with panic disorder treated with cognitive-behavior therapy: outcome and predictors of remission. Behav Res Ther. 2006;44:657\u201365.","journal-title":"Behav Res Ther"},{"key":"2262_CR46","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1590\/S1516-31802011000500008","volume":"129","author":"AL King","year":"2011","unstructured":"King AL, Valen\u00e7a AM, de Melo-Neto VL, Freire RC, Mezzasalma MA, Silva AC, Nardi AE. Efficacy of a specific model for cognitive-behavioral therapy among panic disorder patients with agoraphobia: a randomized clinical trial. Sao Paulo Med J. 2011;129:325\u201334.","journal-title":"Sao Paulo Med J"},{"key":"2262_CR47","first-page":"661","volume":"10","author":"HJ Seo","year":"2014","unstructured":"Seo HJ, Choi YH, Chung YA, Rho W, Chae JH. Changes in cerebral blood flow after cognitive behavior therapy in patients with panic disorder: a SPECT study. J Neuropsychiatr Dis Treat. 2014;10:661\u20139.","journal-title":"J Neuropsychiatr Dis Treat"},{"key":"2262_CR48","doi-asserted-by":"crossref","first-page":"e0123078","DOI":"10.1371\/journal.pone.0123078","volume":"10","author":"T Grochtdreis","year":"2015","unstructured":"Grochtdreis T, Brettschneider C, Wegener A, Watzke B, Riedel-Heller S, H\u00e4rter M, K\u00f6nig HH. Cost-effectiveness of collaborative care for the treatment of depressive disorders in primary care: a systematic review. PLoS One. 2015;10:e0123078.","journal-title":"PLoS One"},{"key":"2262_CR49","doi-asserted-by":"crossref","first-page":"e40808","DOI":"10.1371\/journal.pone.0040808","volume":"7","author":"P McCrone","year":"2012","unstructured":"McCrone P, Sharpe M, Chalder T, Knapp M, Johnson AL, Goldsmith KA, White PD. Adaptive pacing, cognitive behaviour therapy, graded exercise, and specialist medical care for chronic fatigue syndrome: a cost-effectiveness analysis. PLoS One. 2012;7:e40808.","journal-title":"PLoS One"},{"key":"2262_CR50","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1192\/bjp.bp.111.107888","volume":"202","author":"C Mukuria","year":"2013","unstructured":"Mukuria C, Brazier J, Barkham M, Connell J, Hardy G, Hutten R, Saxon D, Dent-Brown K, Parry G. Cost-effectiveness of an improving access to psychological therapies service. Br J Psychiatry. 2013;202:220\u20137.","journal-title":"Br J Psychiatry"},{"key":"2262_CR51","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1177\/0027950107086171","volume":"202","author":"R Layard","year":"2007","unstructured":"Layard R, Clark D, Knapp M, Mayraz G. Cost-benefit analysis of psychological therapy. Natl Inst Econ Rev. 2007;202:90\u20138.","journal-title":"Natl Inst Econ Rev."},{"key":"2262_CR52","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1192\/bjp.179.6.514","volume":"179","author":"D Michelson","year":"2001","unstructured":"Michelson D, Allgulander C, Dantendorfer K, Knezevic A, Maierhofer D, Micev V, Paunovic VR, Timotijevic I, Sarkar N, Skoglund L, Pemberton SC. Efficacy of usual antidepressant dosing regimens of fluoxetine in panic disorder: randomised, placebo-controlled trial. Br J Psychiatry. 2001;179:514\u20138.","journal-title":"Br J Psychiatry"},{"key":"2262_CR53","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1001\/archpsyc.55.11.1010","volume":"55","author":"MH Pollack","year":"1998","unstructured":"Pollack MH, Otto MW, Worthington JJ, Manfro GG, Wolkow R. Sertraline in the treatment of panic disorder a flexible-dose multicenter trial. Arch Gen Psychiatry. 1998;55:1010\u20136.","journal-title":"Arch Gen Psychiatry"},{"key":"2262_CR54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/da.20218","volume":"24","author":"MH Pollack","year":"2007","unstructured":"Pollack MH, Lepola U, Koponen H, Simon NM, Worthington JJ, Emilien G, Tzanis E, Salinas E, Whitaker T, Gao B. A double-blind study of the efficacy of venlafaxine extended-release, paroxetine, and placebo in the treatment of panic disorder. Depress Anxiety. 2007;24:1\u201314.","journal-title":"Depress Anxiety"}],"updated-by":[{"DOI":"10.1186\/s13104-017-2398-y","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2017,2,6]],"date-time":"2017-02-06T00:00:00Z","timestamp":1486339200000}}],"container-title":["BMC Research Notes"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13104-016-2262-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,9]],"date-time":"2022-07-09T18:25:32Z","timestamp":1657391132000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcresnotes.biomedcentral.com\/articles\/10.1186\/s13104-016-2262-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,7]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["2262"],"URL":"https:\/\/doi.org\/10.1186\/s13104-016-2262-5","relation":{},"ISSN":["1756-0500"],"issn-type":[{"value":"1756-0500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,7]]},"article-number":"458"}}